Contact
Please use this form to send email to PR contact of this press release:
Interview released with UBC–An Express Scripts Company: Patient Recruitment&Retention Strategies in Biosimilars Research
TO:
Anna Serazetdinova
SMi Group Ltd
+44702078276180